How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

TN

NASDAQ:TNGX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

TN

Tango Therapeutics IncNASDAQ TNGX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is TNGX undervalued compared to its fair value?

The fair value of TNGX stock is hidden USD. Relative to the market price of 9.67 USD Tango Therapeutics Inc is hidden.

Tango Therapeutics, Inc. operates as a biotechnology company, which engages in discovering and delivering precision cancer medicines. The company is headquartered in Cambridge, Massachusetts and currently employs 109 ful...[More about valuation]

Tango Therapeutics Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

1.051 $B

Price:

9.67 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.35

FINANCIALS

Tango Therapeutics financial for reporting period

Income Statement

0.0065 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.042 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.038 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0065 B 100%
-0.042 B -653%
-0.038 B -586%

Balance Sheet

0.41 B
0.26 B

Financial Position Analysis

Assets

0.41 B
Current Assets
0.35 B
Total non-current assets
0.054 B

Total current liabilities
0.043 B
Total non-current liabilities
0.099 B

Cash Flow Statement

-0.038 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.038 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Tango Therapeutics fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-44 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-592 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-28 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is TNGX attractive for investment based on fundamental analysis?

TNGX stock rating is hidden. Tango Therapeutics is a hidden by Eyestock methodology.

Get TNGX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-300

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

7.484

Debt / Equity ratio:

ROE:

-44

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

TNGX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for TNGX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Tango Therapeutics Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Tango Therapeutics Inc dividends

TNGX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About TNGX stock

About the company Tango Therapeutics Inc

Market cap $B

1.051

Dividend yield

Shares outstanding

88.1774 B

Tango Therapeutics, Inc. operates as a biotechnology company, which engages in discovering and delivering precision cancer medicines. The company is headquartered in Cambridge, Massachusetts and currently employs 109 full-time employees. The company went IPO on 2020-09-03. The Company’s product candidates include TNG908 and ubiquitin-specific protease 1 (USP1). TNG908, is a synthetic lethal, small molecule inhibitor of protein arginine methyltransferase 5 (PRMT5), which is designed to work selectively in cancer cells with a methylthioadenosine phosphorylase (MTAP) deletion. MTAP-deletion occurs in all human tumors, including non-small cell lung cancer (NSCLC), mesothelioma, pancreatic cancer, cholangiocarcinoma and glioblastoma. The firm is focused on initiating a Phase I/II clinical trial. USP1 is a synthetic lethal target discovery screen for BRCA1-mutant breast cancer. The Company’s lead molecules also have activity in BRCA2-mutant patient derived xenografts, including both BRCA1 and BRCA2 mutant models that are intrinsically resistant to polymerase (PARP) inhibition.

TNGX profile

  • Ticker

    TNGX

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    03 September 2020

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    109

  • City

    Cambridge

  • Address

    100 Binney St, Suite 700

  • Cusip

    87583X109